RVTY — Revvity Inc
NYSE · Life Sciences Tools & Services · Life Sciences Tools & Services
- Latest Close
- $87.15
- 30-Day Move
- -13.3%
- Market Cap
- $9.8B
- Shares Outstanding
- 111,800,000
- P/E Ratio
- 40.61
- P/B Ratio
- 1.52
Analyst consensus: Buy · 26 analysts
Revvity Inc
A read-only Alphactor snapshot forRevvity Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-23
Topline snapshot
Latest Close
$87.15
30-Day Move
-13.3%
Market Cap
$9.8B
Shares Outstanding
111,800,000
P/E Ratio
40.61
P/B Ratio
1.52
$87.15
-13.3%last 90 delayed daily bars
90D High
$118.30
90D Low
$82.79
Avg Volume
1,243,856
Gross margin is running at 54.8%, which gives a quick read on operating quality before you open the full model.
Net margin is 8.4%, useful for comparing RVTY against peers in Life Sciences Tools & Services.
RVTY is down 13.3% over the last 30 trading days shown on this page.
Latest operating income is $112M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$47.73
Rule of 40
21.5%
Dark Pool Short %
56.3%
Latest Close
$87.15
30-Day Move
-13.3%
Market Cap
$9.8B
Shares Outstanding
111,800,000
P/E Ratio
40.61
P/B Ratio
1.52
ROE
3.3%
ROA
2.0%
Gross Margin
54.8%
Operating Margin
12.5%
Net Margin
8.4%
Debt / Equity
0.44
Current Ratio
1.68
Dividend Yield
32.0%
Latest Revenue
$772M
Revenue
$772M
Gross Profit
$422M
Operating Income
$112M
Net Income
$98M
Gross Margin
5477.0%
Net Margin
845.0%
Current Ratio
1.68
Debt / Equity
0.44
Fair Value
$47.73
Upside / Downside
-45.2%
Signal
Overvalued
Implied Growth
8.8%
DCF
$27.03
EPV
$10.59
EV/Rev
$105.56
Growth Assumption
-4.8%
Discount Rate
9.0%
Terminal Growth
2.0%
Base FCF
$509M
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Altman Z
2.32
Grey
Piotroski
5
Moderate (4-6)
Cash Conversion
2.42x
Rule of 40
21.5%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $3.3B | $743M | $569M | $594M |
| 2023-12-31 | $2.8B | $301M | $693M | $10M |
| 2024-12-31 | $2.8B | $347M | $270M | $542M |
| 2025-12-31 | $2.9B | $357M | $241M | $509M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
Buy Value
$0
Sell Value
$5M
Buys
0
Sells
15
Buy Value
$0
Sell Value
$5M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-20 | Gonzales Anita | Sell | 80 | $92.80 |
| 2026-03-16 | Gonzales Anita | A | 4,576 | $0.00 |
| 2026-03-16 | Gonzales Anita | A | 1,600 | $0.00 |
| 2026-03-06 | Gonzales Anita | A | 1,616 | $0.00 |
| 2026-03-06 | Gonzales Anita | A | 1,721 | $0.00 |
| 2026-02-24 | Victor Miriame | M | 1,862 | $0.00 |
| 2026-02-24 | Victor Miriame | Sell | 1,862 | $97.13 |
| 2026-02-24 | Victor Miriame | M | 1,862 | $95.74 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 14,366,588 | 0.13% | 2025-12-31 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 5,624,564 | 0.05% | 2025-12-31 |
| -Price (T.Rowe) U.S. Value Equity Trust | 3,924,092 | 0.04% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3,568,953 | 0.03% | 2025-12-31 |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 3,124,254 | 0.03% | 2025-12-31 |
| T. Rowe Price Value Fund, Inc. | 3,027,497 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2,857,090 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2,569,977 | 0.02% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
BlackRock
Filed 2024-08-13
$921M
--
Capital Research Global Investors
Filed 2025-05-12
$300M
--
Citadel Advisors
Filed 2026-02-17
$12M
--
Marshall Wace
Filed 2026-02-13
$11M
--
Man Group
Filed 2026-02-17
$9M
+262.1%
3.77
Consensus
Buy—
—
—
26
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.